|
|
|
Volumn 7, Issue 6, 2007, Pages 450-451
|
|
Trastuzumab prolongs progression-free survival in patients with hormone-sensitive and HER2-overexpressing metastatic breast cancer
a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
TRASTUZUMAB;
ADULT;
AGED;
BREAST CANCER;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONFERENCE PAPER;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG FATALITY;
DRUG SAFETY;
DRUG TOLERABILITY;
FATIGUE;
FEVER;
FLUORESCENCE IN SITU HYBRIDIZATION;
HEART ARRHYTHMIA;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LIVER METASTASIS;
MAJOR CLINICAL STUDY;
MONOTHERAPY;
NAUSEA;
OVERALL SURVIVAL;
PROTEIN EXPRESSION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT RESPONSE;
VOMITING;
|
|
EID: 33947242929
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|